Market Forecast By Prescription Type (Prescription Drugs, Over-the-Counter Drugs), By Drug Type (Branded Drugs, Generic Drugs, Branded Generic Drugs), By Drug Class (Small Molecules, Biologics, Biosimilars), By Indication (Cardiovascular Diseases, Immunology, Respiratory Diseases, Neurological Diseases, Infectious Diseases, Skin Diseases), By Mode of Administration (Topical, Oral, Injectable, Intra-nasal, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Drug Stores, Online Pharmacies) And Competitive Landscape
| Product Code: ETC8718848 | Publication Date: Sep 2024 | Updated Date: Dec 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Deep | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
According to 6Wresearch internal database and industry insights, the Pakistan Pharmaceutical Market is projected to grow steadily at a compound annual growth rate (CAGR) of 8.9% during the forecast period from 2026 to 2032.
Below mentioned are the evaluation of year-wise growth rate along with key drivers:
|
Year |
Est. Annual Growth (%) |
Growth Drivers |
|
2021 |
7.2% |
Growing spending on healthcare and rising awareness about chronic diseases. |
|
2022 |
7.5% |
Expansion of retail pharmacies and increased capacity of local manufacturing. |
|
2023 |
7.8% |
Government laws in drug pricing policy and improved efficiency of laws. |
|
2024 |
8% |
Rising exports of pharmaceutical and usage of digital platforms in healthcare. |
|
2025 |
8.3% |
Increased support by government for promotion of export and health insurance schemes. |
The Pakistan Pharmaceutical Market report thoroughly covers the market by prescription type, drug type, drug class, indication, mode of administration, and distribution channel. It provides an unbiased and detailed analysis of ongoing market trends, opportunities, challenges, and market drivers, helping stakeholders align their strategies with current and future market dynamics.
| Report Name | Pakistan Pharmaceutical Market |
| Forecast Period | 2026–2032 |
| CAGR | 8.9% |
| Growing Sector | Healthcare & Pharmaceuticals |
Pakistan Pharmaceutical Market is expected to experience major growth as it is driven by rising risks of chronic disease, developing better healthcare infrastructure, supportive policies by government to reduce prices of drug, and growing exports in pharmaceutical industry. The local pharmaceutical market of Pakistan has crossed PKR 1 trillion in annual sales and still continues to expand more as it is supported by local manufacturers and multinational companies. The increased risks of chronic and lifestyle-related diseases are also creating long-term dependence on prescription therapies and high awareness about health and self-medication trends are creating steady demand for OTC products in urban and semi-urban regions.
Below mentioned are some prominent drivers and their impact on the Pakistan Pharmaceutical Market dynamics:
| Drivers | Primary Segment Affected | Why It Matters |
| Rising Prevalence of Chronic Diseases | Prescription Drugs, OTC Drugs | Increased patients of diabetes, cardiovascular and respiratory diseases is creating long‑term medication demand. |
| Government Healthcare Programs and Pricing Reforms | All Segments | Reforms like deregulation of pricing and health insurance programs decrease prices of medicines. |
| Export Promotion Strategies | All Segments | Programmes such as PharmEx Pakistan and export facilitation councils have increased export growth. |
| Expansion of Retail and Hospital Pharmacies | All Segments | Growing sales networks improve availability of medicines in urban and rural areas. |
| Increased Health Awareness | All Segments | Rising knowledge about health increases demand for both prescription and OTC drugs. |
Pakistan Pharmaceutical Market Size is expected to grow at a CAGR of 8.9% from 2026 to 2032. Demand for prescription medications, over-the-counter (OTC) drugs, and biosimilars will create major expansion of the Pakistan Pharmaceutical Market in the upcoming years. The increased risks of chronic and lifestyle-related diseases are also creating long-term dependence on prescription therapies and high awareness about health and self-medication trends are creating steady demand for OTC products in urban and semi-urban regions. At the same time, biosimilars are also gaining major popularity due to their less price and high acceptance among healthcare providers. Strong government support by healthcare financing programs and incentives for export-oriented manufacturing is improving Pakistan Pharmaceutical Market Growth.
Below mentioned are some major restraints and their influence on the Pakistan Pharmaceutical Market dynamics:
| Restraints | Primary Segment Affected | What This Means |
| High Cost of Branded Drugs | Branded Drugs | High prices reduce sales among lower‑income consumers. |
| Regulatory Compliance Complexities | All Segments | Lengthy approval processes can delay introductions of new product. |
| Import Dependence on APIs | All Segments | Heavy dependence on imported pharmaceutical ingredients creates vulnerabilities in supply. |
| Economic Constraints | All Segments | Fluctuations in currency and economic pressures reduce purchasing power of consumers. |
| Counterfeit Drugs | OTC and Generic Drugs | Frauds products reduce consumer’s confidence and pose health risks. |
Pakistan Pharmaceutical Market faces many challenges such as regulatory difficulties, high dependency on imported raw materials, economic pressures on healthcare spending, and the presence of counterfeit drugs. Limited local production of APIs can also delay product approvals and increase competition. Slow development of advanced therapies and their limited awareness in rural areas may also restrict market’s demand. Some distribution channels and logistical inefficiencies also increase time of delivery of essential medicines across the country.
Major trends shaping the Pakistan Pharmaceutical Market include:
Key investment opportunities in Pakistan Pharmaceutical Industry include:
Below is the list of prominent companies leading in the Pakistan Pharmaceutical Market:
| Company Name | Sun Pharmaceutical Industries Ltd. |
| Established Year | 1983 |
| Headquarters | Mumbai, India |
| Official Website | Click Here |
Offers a broad range of branded and generic drugs with presence in Pakistan through distribution networks. The company focuses on chronic therapies such as cardiology, dermatology, and oncology, strengthening its footprint in key therapeutic segments.
| Company Name | Getz Pharma |
| Established Year | 1950 |
| Headquarters | Karachi, Pakistan |
| Official Website | Click Here |
One of Pakistan’s largest domestic pharma companies, known for generic medicines and strong market presence. Getz Pharma emphasizes quality manufacturing standards and has a wide distribution reach across both urban and rural markets.
| Company Name | GlaxoSmithKline Pakistan Ltd. (GSK) |
| Established Year | 1856 |
| Headquarters | London, UK |
| Official Website | Click Here |
Multinational company with extensive portfolio in respiratory, vaccines, and consumer healthcare. GSK Pakistan plays a significant role in preventive healthcare and essential medicines through strong brand recognition.
| Company Name | The Searle Company Ltd. |
| Established Year | 1965 |
| Headquarters | Karachi, Pakistan |
| Official Website | Click Here |
Leading local manufacturer with strong presence in various therapeutic areas. The company focuses on research-driven product development and expanding its branded generics portfolio.
| Company Name | Abbott Laboratories Pakistan Ltd. |
| Established Year | 1888 |
| Headquarters | Abbott Park, Illinois, USA |
| Official Website | Click Here |
Global healthcare company with significant operations in Pakistan, offering diverse pharmaceutical products. Abbott maintains a strong position in nutrition, diagnostics, and chronic disease management therapies.
According to Pakistan’s government data, The Drug Regulatory Authority of Pakistan (DRAP) regulates drug approvals and pricing. Recent laws include the deregulation of non essential medicine prices and digital programs to make licensing and registration process easier, accelerating timelines of market entry. Government support on export such as less duties on APIs and the establishment of export support bodies like PharmEx Pakistan increase competitiveness and global reach. Social health insurance schemes like Sehat Sahulat Program also improve access of medicines for vulnerable populations.
Pakistan Pharmaceutical Market is expected to continue its growth in upcoming years as it is driven by government support, rising spending on healthcare, growing risks of chronic disease, export expansion, and increasing usage of digital health services. Expansion of local manufacturing capacity and regulatory efficiency will also strengthen market’s position as in the global industry. The market has a major growth potential due to the increasing demand for prescription and over-the-counter medications in all age groups. The increasing usage of generics and biosimilars and partnerships with international pharmaceutical companies, will also likely to increase demand in the Pakistan’s market.
The report offers a comprehensive study of the following market segments and their leading categories:
According to Lakshita, Senior Research Analyst, 6Wresearch, Prescription drugs lead the market due to high risks of chronic conditions requiring long term therapy, such as cardiovascular and diabetes medications. These drugs are important for managing complex health issues in all age groups.
Generic medicines dominate Pakistan’s pharmaceutical market due to reduced prices, widespread availability, and strong local production capabilities and reducing the dependence on imported branded products.
Small molecules form the largest segment due to their wide usage in treating chronic and acute conditions and ease of production compared to biologics. Demand for biosimilars and biologics is also increasing with growth in specialty treatment areas.
Infectious Diseases dominate the market as it is driven by high risks of heart conditions and hypertension in the population. Other diseases such as respiratory and metabolic diseases are also spreading steadily.
Oral drugs are the dominant mode due to their ease of use, patient compliance, and cost effectiveness. Injectable formulations are typically used in hospital settings and specialty treatments while other modes still remain smaller.
Retail pharmacies hold the largest Pakistan Pharmaceutical Market Share, due to their accessibility and convenience for consumers. Hospital pharmacies remain important for prescription medicines, while online pharmacies are gradually increasing.
The report offers a comprehensive study of the following Pakistan Pharmaceutical Market segments:
| 1 Executive Summary |
| 2 Introduction |
| 2.1 Key Highlights of the Report |
| 2.2 Report Description |
| 2.3 Market Scope & Segmentation |
| 2.4 Research Methodology |
| 2.5 Assumptions |
| 3 Pakistan Pharmaceutical Market Overview |
| 3.1 Pakistan Country Macro Economic Indicators |
| 3.2 Pakistan Pharmaceutical Market Revenues & Volume, 2022 & 2032F |
| 3.3 Pakistan Pharmaceutical Market - Industry Life Cycle |
| 3.4 Pakistan Pharmaceutical Market - Porter's Five Forces |
| 3.5 Pakistan Pharmaceutical Market Revenues & Volume Share, By Prescription Type, 2022 & 2032F |
| 3.6 Pakistan Pharmaceutical Market Revenues & Volume Share, By Drug Type, 2022 & 2032F |
| 3.7 Pakistan Pharmaceutical Market Revenues & Volume Share, By Drug Class, 2022 & 2032F |
| 3.8 Pakistan Pharmaceutical Market Revenues & Volume Share, By Indication, 2022 & 2032F |
| 3.9 Pakistan Pharmaceutical Market Revenues & Volume Share, By Mode of Administration, 2022 & 2032F |
| 3.10 Pakistan Pharmaceutical Market Revenues & Volume Share, By Distribution Channel, 2022 & 2032F |
| 4 Pakistan Pharmaceutical Market Dynamics |
| 4.1 Impact Analysis |
| 4.2 Market Drivers |
| 4.2.1 Increasing healthcare spending in Pakistan |
| 4.2.2 Growing population and increasing healthcare needs |
| 4.2.3 Government initiatives to improve healthcare infrastructure |
| 4.3 Market Restraints |
| 4.3.1 Price control regulations impacting profitability |
| 4.3.2 Limited access to quality healthcare services in rural areas |
| 4.3.3 Counterfeit and substandard drugs affecting market reputation |
| 5 Pakistan Pharmaceutical Market Trends |
| 6 Pakistan Pharmaceutical Market, By Types |
| 6.1 Pakistan Pharmaceutical Market, By Prescription Type |
| 6.1.1 Overview and Analysis |
| 6.1.2 Pakistan Pharmaceutical Market Revenues & Volume, By Prescription Type, 2022- 2032F |
| 6.1.3 Pakistan Pharmaceutical Market Revenues & Volume, By Prescription Drugs, 2022- 2032F |
| 6.1.4 Pakistan Pharmaceutical Market Revenues & Volume, By Over-the-Counter Drugs, 2022- 2032F |
| 6.2 Pakistan Pharmaceutical Market, By Drug Type |
| 6.2.1 Overview and Analysis |
| 6.2.2 Pakistan Pharmaceutical Market Revenues & Volume, By Branded Drugs, 2022- 2032F |
| 6.2.3 Pakistan Pharmaceutical Market Revenues & Volume, By Generic Drugs, 2022- 2032F |
| 6.2.4 Pakistan Pharmaceutical Market Revenues & Volume, By Branded Generic Drugs, 2022- 2032F |
| 6.3 Pakistan Pharmaceutical Market, By Drug Class |
| 6.3.1 Overview and Analysis |
| 6.3.2 Pakistan Pharmaceutical Market Revenues & Volume, By Small Molecules, 2022- 2032F |
| 6.3.3 Pakistan Pharmaceutical Market Revenues & Volume, By Biologics, 2022- 2032F |
| 6.3.4 Pakistan Pharmaceutical Market Revenues & Volume, By Biosimilars, 2022- 2032F |
| 6.4 Pakistan Pharmaceutical Market, By Indication |
| 6.4.1 Overview and Analysis |
| 6.4.2 Pakistan Pharmaceutical Market Revenues & Volume, By Cardiovascular Diseases, 2022- 2032F |
| 6.4.3 Pakistan Pharmaceutical Market Revenues & Volume, By Immunology, 2022- 2032F |
| 6.4.4 Pakistan Pharmaceutical Market Revenues & Volume, By Respiratory Diseases, 2022- 2032F |
| 6.4.5 Pakistan Pharmaceutical Market Revenues & Volume, By Neurological Diseases, 2022- 2032F |
| 6.4.6 Pakistan Pharmaceutical Market Revenues & Volume, By Infectious Diseases, 2022- 2032F |
| 6.4.7 Pakistan Pharmaceutical Market Revenues & Volume, By Skin Diseases, 2022- 2032F |
| 6.5 Pakistan Pharmaceutical Market, By Mode of Administration |
| 6.5.1 Overview and Analysis |
| 6.5.2 Pakistan Pharmaceutical Market Revenues & Volume, By Topical, 2022- 2032F |
| 6.5.3 Pakistan Pharmaceutical Market Revenues & Volume, By Oral, 2022- 2032F |
| 6.5.4 Pakistan Pharmaceutical Market Revenues & Volume, By Injectable, 2022- 2032F |
| 6.5.5 Pakistan Pharmaceutical Market Revenues & Volume, By Intra-nasal, 2022- 2032F |
| 6.5.6 Pakistan Pharmaceutical Market Revenues & Volume, By Others, 2022- 2032F |
| 6.6 Pakistan Pharmaceutical Market, By Distribution Channel |
| 6.6.1 Overview and Analysis |
| 6.6.2 Pakistan Pharmaceutical Market Revenues & Volume, By Hospital Pharmacies, 2022- 2032F |
| 6.6.3 Pakistan Pharmaceutical Market Revenues & Volume, By Retail Pharmacies, 2022- 2032F |
| 6.6.4 Pakistan Pharmaceutical Market Revenues & Volume, By Drug Stores, 2022- 2032F |
| 6.6.5 Pakistan Pharmaceutical Market Revenues & Volume, By Online Pharmacies, 2022- 2032F |
| 7 Pakistan Pharmaceutical Market Import-Export Trade Statistics |
| 7.1 Pakistan Pharmaceutical Market Export to Major Countries |
| 7.2 Pakistan Pharmaceutical Market Imports from Major Countries |
| 8 Pakistan Pharmaceutical Market Key Performance Indicators |
| 8.1 Number of new drug approvals by regulatory authorities |
| 8.2 Investment in research and development by pharmaceutical companies |
| 8.3 Percentage of the population covered by health insurance |
| 8.4 Number of pharmacies and healthcare facilities in underserved regions |
| 8.5 Rate of adoption of digital healthcare solutions |
| 9 Pakistan Pharmaceutical Market - Opportunity Assessment |
| 9.1 Pakistan Pharmaceutical Market Opportunity Assessment, By Prescription Type, 2022 & 2032F |
| 9.2 Pakistan Pharmaceutical Market Opportunity Assessment, By Drug Type, 2022 & 2032F |
| 9.3 Pakistan Pharmaceutical Market Opportunity Assessment, By Drug Class, 2022 & 2032F |
| 9.4 Pakistan Pharmaceutical Market Opportunity Assessment, By Indication, 2022 & 2032F |
| 9.5 Pakistan Pharmaceutical Market Opportunity Assessment, By Mode of Administration, 2022 & 2032F |
| 9.6 Pakistan Pharmaceutical Market Opportunity Assessment, By Distribution Channel, 2022 & 2032F |
| 10 Pakistan Pharmaceutical Market - Competitive Landscape |
| 10.1 Pakistan Pharmaceutical Market Revenue Share, By Companies, 2025 |
| 10.2 Pakistan Pharmaceutical Market Competitive Benchmarking, By Operating and Technical Parameters |
| 11 Company Profiles |
| 12 Recommendations |
| 13 Disclaimer |